Tehila Mishraki

Title: Tehila Mishraki: Innovator in Liquid Crystal Technology

Introduction

Tehila Mishraki is a prominent inventor based in Jerusalem, Israel. She has made significant contributions to the field of liquid crystal technology, particularly in the development of systems that enhance the delivery of bio-macromolecules and active materials. Her innovative work has implications for both therapeutic and non-therapeutic applications.

Latest Patents

Tehila Mishraki holds 1 patent related to reverse hexagonal mesophase (H) liquid crystals. This patent provides multi-component hexagonal systems designed for solubilizing and protecting bio-macromolecules and active materials from degradation. The invention is particularly relevant for oral delivery systems, where the mesophase is adapted for oral administration. It involves the formation of mesophase systems using ternary glycerol monooleate (GMO)/water combinations, which include at least one triglyceride or an equivalent. The patent also incorporates at least one biomacromolecule or drug within the mesophase of a pharmaceutical composition or oral delivery system.

Career Highlights

Tehila Mishraki is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Her work at this esteemed institution has allowed her to explore innovative solutions in the field of liquid crystals and their applications in medicine.

Collaborations

Tehila has collaborated with notable colleagues, including Nissim Garti and Abraham Aserin. These partnerships have contributed to her research and the advancement of her inventions.

Conclusion

Tehila Mishraki's contributions to liquid crystal technology exemplify her innovative spirit and dedication to enhancing drug delivery systems. Her work continues to impact the field significantly.